Marit Vermunt
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 25, 2022
Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients.Marit A C Vermunt, Merel van Nuland, Lisa T van der Heijden
|Mar 21, 2021
Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours.Marit A C Vermunt, Lisa T van der Heijden, Jeroen J M A Hendrikx
|Mar 12, 2021
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration-resistant prostate cancer patients: A phase Ib study.Marit A C Vermunt, Debbie G J Robbrecht, Lot A Devriese
|Feb 04, 2021
Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials.Marit Vermunt, Serena Marchetti, Jos Beijnen
|Jan 19, 2021
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours.Marit A C Vermunt, Vincent A de Weger, Julie M Janssen
|Dec 28, 2020
The intravenous to oral switch of taxanes: strategies and current clinical developments.Marit Ac Vermunt, Andries M Bergman, Eric van der Putten
Pageof 1
